Moreover, KRAS-mutant NSCLC in smoker patients are genomically more complex, with a higher mutational burden and higher frequency of additional mutations in TP53 or STK11 genes compared to never smoker tumors, as result of antigenic exposure and oxidative stress in epithelial cells (17). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.